This course reviews syphilis screening, how to interpret results and stage disease, and syphilis treatment recommendations based on stage of disease.
At the conclusion of the session, the participant should be able to:
- Describe the diagnostic considerations for syphilis.
- Describe how to treat syphilis.
- Describe the importance of interprofessional collaboration in screening for and treating syphilis.
FACULTY/CREDENTIALS:
Alexandra Filipkowski, BS, MPH candidate (’24), Intern, New York City STD Prevention Training Center
Natalie Neu, MD MPH, Medical Director, NYC STD Prevention Training Center; Associate Professor of Pediatrics/ Fellowship Director, Columbia University Medical Center Pediatric Infectious Disease
Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
Jason Zucker, MD MS, Assistant Professor, Divisions of Adult and Pediatric Infectious Diseases, Columbia University Medical Center; Assistant Medical Director, New York City STD Prevention Training Center
ORIGINATION DATE: April 1, 2024
EXPIRATION DATE: April 1, 2026
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS: None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and other healthcare professionals
PREREQUISITES: Intended for clinicians who provide clinical care for patients with STIs.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu
ACCREDITATION STATEMENTS:
|
|
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD/HIV Prevention Training Center. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 0.75 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE:
In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
Instructions for claiming CE are provided at the end of this course.
FEES: No fees are charged for CDC’s CE activities.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.